Literature DB >> 25001982

Bone mineral density in men and children with haemophilia A and B: a systematic review and meta-analysis.

S A Paschou1, P Anagnostis, S Karras, C Annweiler, S Vakalopoulou, V Garipidou, D G Goulis.   

Abstract

SUMMARY: Although haemophilia is not considered among the classic causes of secondary osteoporosis, the present meta-analysis provides strong evidence that men with haemophilia have a significant reduction in both lumbar spine and femoral bone mineral density, which appears to begin in childhood.
INTRODUCTION: Haemophilia is not considered among the classic causes of secondary osteoporosis. The aim of this study was to systematically review the literature for case-control trials that have studied bone mass in males with haemophilia and to meta-analyze the best evidence available.
METHODS: Electronic databases MEDLINE, EMBASE and CENTRAL were systematically searched for case-control trials that have studied bone mass in men or boys with haemophilia. Standardized mean difference (SMD) for bone mineral density (BMD) in the lumbar spine was the main study outcome and SMD in femoral neck and total hip BMD the secondary ones. Patient and control characteristics, such as age, body mass index (BMI), level of physical activity and blood-borne infections were recorded as possible predictors of the main outcome.
RESULTS: Thirteen studies were included in the systematic review and ten in the main outcome meta-analysis. Men with haemophilia demonstrated reduced lumbar spine [random effects SMD [95 % confidence interval (CI)] = -0.56 (-0.84, -0.28), between-study heterogeneity (I (2)) = 51 %] and femoral neck BMD [random effects SMD (95 % CI) = -0.82 (-1.21, -0.44), I (2) = 63 %] compared with controls, which indicated a large and clinically significant association. Similar results were obtained for children [random effects SMD (95 % CI) = -0.92 (-1.77, -0.07), I (2) = 92 %]. No evidence of publication bias was detected. There was no evidence that age, BMI, level of physical activity or presence of blood-borne infections predicted lumbar spine BMD.
CONCLUSIONS: This meta-analysis shows that men with haemophilia present a significant reduction in both lumbar spine and hip BMD, which appears to begin in childhood.

Entities:  

Mesh:

Year:  2014        PMID: 25001982     DOI: 10.1007/s00198-014-2773-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  28 in total

1.  A program to compute McGraw and Wong's common language effect size indicator.

Authors:  W P Dunlap
Journal:  Behav Res Methods Instrum Comput       Date:  1999-11

Review 2.  Osteoporosis.

Authors:  Philip Sambrook; Cyrus Cooper
Journal:  Lancet       Date:  2006-06-17       Impact factor: 79.321

3.  Reduced bone mineral density in patients with haemophilia A and B in Northern Greece.

Authors:  Panagiotis Anagnostis; Sofia Vakalopoulou; Aristidis Slavakis; Maria Charizopoulou; Eirini Kazantzidou; Tania Chrysopoulou; Timoleon-Achilleas Vyzantiadis; Eleni Moka; Alexandra Agapidou; Vassilia Garipidou
Journal:  Thromb Haemost       Date:  2012-02-08       Impact factor: 5.249

Review 4.  Clinical practice. Osteoporosis in men.

Authors:  Peter R Ebeling
Journal:  N Engl J Med       Date:  2008-04-03       Impact factor: 91.245

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Evaluation of bone mineral density in Turkish children with severe haemophilia A: Ankara hospital experience.

Authors:  B Alioglu; B Selver; H Ozsoy; G Koca; M Ozdemir; Y Dallar
Journal:  Haemophilia       Date:  2011-06-09       Impact factor: 4.287

Review 7.  Osteoporosis in men.

Authors:  Evelien Gielen; Dirk Vanderschueren; Filip Callewaert; Steven Boonen
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-04       Impact factor: 4.690

8.  Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia.

Authors:  G Gerstner; M L Damiano; A Tom; C Worman; W Schultz; M Recht; A T Stopeck
Journal:  Haemophilia       Date:  2009-02-01       Impact factor: 4.287

9.  Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study.

Authors:  S J Gallacher; C Deighan; A M Wallace; R A Cowan; W D Fraser; J A Fenner; G D Lowe; I T Boyle
Journal:  Q J Med       Date:  1994-03

10.  Bone mineral density in haemophilia patients. A meta-analysis.

Authors:  Alfonso Iorio; Gianluigi Fabbriciani; Maura Marcucci; Matteo Brozzetti; Paolo Filipponi
Journal:  Thromb Haemost       Date:  2010-01-13       Impact factor: 5.249

View more
  15 in total

1.  Evaluation of bone mineral density and related parameters in patients with haemophilia: a single center cross-sectional study.

Authors:  Hatice Demet Kiper Unal; Melda Comert Ozkan; Fatos Dilan Atilla; Zuhal Demirci; Nur Soyer; Ilgin Yildirim Simsir; Ozgur Omur; Kazim Capaci; Guray Saydam; Fahri Sahin
Journal:  Am J Blood Res       Date:  2017-11-01

2.  Serum Sclerostin Level and Bone Mineral Density in Pediatric Hemophilic Arthropathy.

Authors:  Dalia M E El-Mikkawy; Mohja A Elbadawy; Shereen M Abd El-Ghany; Dalia Samaha
Journal:  Indian J Pediatr       Date:  2019-01-22       Impact factor: 1.967

Review 3.  Management of Hemophilia in Older Patients.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

4.  Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway.

Authors:  Coline Haxaire; Narine Hakobyan; Tania Pannellini; Camila Carballo; David McIlwain; Tak W Mak; Scott Rodeo; Suchitra Acharya; Daniel Li; Jackie Szymonifka; Xiangqian Song; Sébastien Monette; Alok Srivastava; Jane E Salmon; Carl P Blobel
Journal:  Blood       Date:  2018-05-18       Impact factor: 22.113

Review 5.  Bone Density Status in Bleeding Disorders: Where Are We and What Needs to Be Done?

Authors:  Hassan Mansouritorghabeh; Zahra Rezaieyazdi
Journal:  J Bone Metab       Date:  2017-11-30

6.  Hemophilia A and B mice, but not VWF-/-mice, display bone defects in congenital development and remodeling after injury.

Authors:  Sarah Taves; Junjiang Sun; Eric W Livingston; Xin Chen; Jerome Amiaud; Regis Brion; William B Hannah; Ted A Bateman; Dominique Heymann; Paul E Monahan
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

Review 7.  Hematological Diseases and Osteoporosis.

Authors:  Agostino Gaudio; Anastasia Xourafa; Rosario Rapisarda; Luca Zanoli; Salvatore Santo Signorelli; Pietro Castellino
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

8.  Clinical Care of Bone Health in Patients on the Immune Tolerance Induction's Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia.

Authors:  Zahra Rezaieyazdi; Hassan Mansouritorghabeh
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

9.  PHILEOS (haemoPHILia and ostEoporOSis) Study: protocol of a multicentre prospective case-control study.

Authors:  Brigitte Tardy-Poncet; Barbara Play; Aurélie Montmartin; Pauline Damien; Edouard Ollier; Emilie Presles; Arnauld Garcin; Bernard Tardy
Journal:  BMJ Open       Date:  2021-01-13       Impact factor: 2.692

10.  Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study.

Authors:  Grace H Tang; Erin Norris; Jessica Petrucci; Paula D James; Adrienne Lee; Man-Chiu Poon; Georgina Floros; Laurence Boma-Fischer; Jerry Teitel; Rosane Nisenbaum; Michelle Sholzberg
Journal:  BMJ Open       Date:  2019-12-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.